推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733，021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

System and method for diagnosing and monitoring congestive heart failure

GH Bardy - US Patent 7,874,993, 2011 - Google Patents
Illllllllllllllllllllllllllllllllllllllllllllllllll US007874993B2 (12) United States Patent Bardy (io) Patent
No.: (45) Date of Patent: US 7,874,993 B2 *Jan. 25, 2011 (54) SYSTEM AND METHOD FOR
DIAGNOSING AND MONITORING CONGESTIVE HEART FAILURE (75) Inventor: Gust H. ...
Related articles - All 4 versions

… I/IIA FIRST IN MAN SAFETY AND TOLERABILITY STUDY OF A NOVEL HNO DONOR, CXL-1020, IN PATIENTS WITH STABLE CONGESTIVE HEART FAILURE

D Cowart, J Aranda, G Haas… - Journal of the …, 2011 - Am Coll Cardio Found
... Mazhari, Vince Kalish, and Wilson Colucci Doug Cowart, Juan Aranda, Garrie Haas, Joel Neutel,
William Smith, Reza CONGESTIVE HEART FAILURE A NOVEL HNO DONOR, CXL-1020, IN
PATIENTS WITH STABLE A PHASE I/IIA FIRST IN MAN SAFETY AND TOLERABILITY ...
All 2 versions

The association between hospital volume and processes, outcomes, and costs of care for congestive heart failure

KE Joynt, EJ Orav… - Annals of internal medicine, 2011 - Am Coll Physicians
... The Association Between Hospital Volume and Processes, Outcomes, and Costs of Care for
Congestive Heart Failure. ... Abstract. Background: Congestive heart failure (CHF) is common and
costly, and outcomes remain suboptimal despite pharmacologic and technical advances. ...
Cited by 3 - Related articles - All 5 versions

Hospital Volume and Processes, Outcomes, and Costs of Care for Congestive Heart Failure

KE Joynt, EJ Orav… - Annals of Internal Medicine, 2011 - Am Coll Physicians
TO THE EDITOR: Although some studies suggest that patients aged 75 years or older derive
benefit from primary prophylactic implant- able cardioverter-defibrillator (ICD) therapy similar
to that of their younger counterparts (1), consideration of age and noncardiac co- morbid ...

Incidence and Risk of Congestive Heart Failure in Patients With Renal and Nonrenal Cell Carcinoma Treated With Sunitinib

[HTML] from jcojournal.orgCJ Richards, Y Je, FAB Schutz… - Journal of Clinical …, 2011 - jcojournal.org
Purpose Sunitinib is a multitargeted receptor tyrosine kinase inhibitor approved for treatment
of renal cell carcinoma (RCC) and GI stromal tumor. Congestive heart failure (CHF) is an important
adverse effect that has been reported with sunitinib, but overall incidence and relative risk ...

联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

© 2010-2024 中国: LetPub上海分公司    网站备案号：沪ICP备10217908号-1    沪公网安备号：31010402006960

增值电信业务经营许可证：沪B2-20211595

礼翰商务信息咨询（上海）有限公司      办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室

United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451